Investment
Features
FeesSafety
Academy
More
Pluang+

Strategy sells 3,588 Bitcoin quietly, marking a shift from its 'never sell' policy.

Market News
28 Jul 2026
Crypto Briefing
View Source
Neutral
pluang ai news

Michael Saylor's company Strategy sold 3,588 Bitcoin for about $216 million in early July 2026, its largest-ever Bitcoin liquidation. This sale was done quietly without issuing new shares or suspending dividends, signaling a shift from the company's previous strict "never sell" approach. Strategy still holds around 843,775 BTC but made no new purchases immediately after the sale. Meanwhile, Metaplanet is aggressively accumulating Bitcoin and developing yield products, indicating a new phase in corporate Bitcoin strategies focused on generating returns rather than just holding.

More News

AGC Biologics secures multi-year, multi-million dollar commercial production deal for new Yokohama biopharma site.

AGC Biologics secures multi-year, multi-million dollar commercial production deal for new Yokohama biopharma site.

AGC Biologics has signed a multi-year commercial manufacturing agreement with a major pharmaceutical company for its new Yokohama facility, locking in half of the mammalian cell production capacity. The deal, worth hundreds of millions of dollars, co...

Company Fundamentals
Bullish
34 minutes ago
AGC Biologics secures multi-year commercial manufacturing deal worth hundreds of millions for new Yokohama site.

AGC Biologics secures multi-year commercial manufacturing deal worth hundreds of millions for new Yokohama site.

AGC Biologics has signed a multi-year commercial manufacturing contract valued at hundreds of millions of dollars with a major biopharma company for its new Yokohama facility. The contract covers production of five biopharmaceutical programs, securin...

Company Fundamentals
Bullish
34 minutes ago
AGC Biologics signs multi-year commercial production deal worth hundreds of millions for new Yokohama facility.

AGC Biologics signs multi-year commercial production deal worth hundreds of millions for new Yokohama facility.

AGC Biologics has secured a long-term commercial manufacturing contract with a global biopharma company for its new Yokohama facility, expected to generate hundreds of millions of dollars. The contract covers production of five biopharmaceutical prod...

Company Fundamentals
Bullish
34 minutes ago
Seagate surges on Q4 earnings beat and AI-driven data storage demand

Seagate surges on Q4 earnings beat and AI-driven data storage demand

Seagate Technology reported strong Q4 2026 results, beating earnings per share estimates with $5.71 and revenue of $3.63 billion, driven by high demand for data storage from the AI sector. The company showed solid financial health with a low debt-to-...

Company Fundamentals
Bullish
2 hours ago
Replimune stock plunges 38% after FDA flags clinical trial issues for skin cancer drug

Replimune stock plunges 38% after FDA flags clinical trial issues for skin cancer drug

Replimune Group's stock fell sharply by 38.01% following FDA briefing documents that deemed its skin cancer drug trial data "not interpretable," signaling a major regulatory setback. Other companies like Travelzoo and Amkor Technology also saw signif...

Market News
Bearish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App